Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo (Q39908534)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo |
scientific article |
Statements
1 reference
Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo (English)
1 reference
Ebba Palmberg
1 reference
John Inge Johnsen
1 reference
Janna Paulsson
1 reference
Helena Gleissman
1 reference
Margareta Edgren
1 reference
Arne Ostman
1 reference
Magnus Lindskog
1 reference
1 March 2009
1 reference
1 reference
124
1 reference
5
1 reference
1227-1234
1 reference
1 reference
Identifiers
1 reference
1 reference